Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 21Observational 2

Sponsor

Cancer Type

Breast 7Gastrointestinal 6Genitourinary 5Plasma cell 4Thoracic 2Other hematologic neoplasm 2Lymphoid 2Dermatologic 2Tumor-Agnostic 1Sarcoma 1Myeloid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Sezary Syndrome 1Lymphoma 1

Interventions

Rituximab 29Surveys and Questionnaires 25Blood Specimen Collection 17Gene Expression Profiling 15Flow Cytometry 14Polymerase Chain Reaction 13Amplified Fragment Length Polymorphism Analysis 13Microarray Analysis 11Observation 10Interviews as Topic 10Psychiatric Rehabilitation 9Lenalidomide 9Immunohistochemistry 9Cytogenetic Analysis 9obinutuzumab 8Watchful Waiting 8Therapeutics 8ibrutinib 7Drug Therapy 7Cyclophosphamide 7Bendamustine Hydrochloride 7Vincristine 6Prednisone 6Magnetic Resonance Spectroscopy 6fludarabine 5In Situ Hybridization, Fluorescence 5Immunologic Techniques 5Data Collection 5Brentuximab Vedotin 5Biopsy 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Standard of Care × Lymphoid × Clear all
NCT05206045 2022-01-25

SURPASSe

Assistance Publique - Hôpitaux de Paris

Unknown
700 enrolled
Lymphoid

Sezary Syndrome

NCT02370446 2017-01-11

Testing a Personalize Medication Log for Patients With Lymphoma

Memorial Sloan Kettering Cancer Center

Completed
5 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡